Astellas Provides Update on Fezolinetant New Drug Application in U.S.
Go back to Astellas Provides Update on Fezolinetant New Drug Application in U.S.| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 15.11 +0.69 (4.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.42 | 52 Week High | $19.40 | |||
| Open | $15.00 | 52 Week Low | $12.50 | |||
| Day High | $15.16 | P/E | N/A | |||
| Day Low | $14.76 | EPS | $0.00 | |||
| Volume | 178,364 | |||||
